Astrana Health Overview
Astrana Health Target Price
Analysts' 12-month price predictions for ASTH.
Get informed when a big investor buys or sells
+ FollowShare Price
$37.85
Average Target Price
$43.33
14.5% upside
14.5% upside6 analysts in the last 4 months
High: $50 | Low: $37
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-26 | Barclays | $50 | 32.1% upside |  |
| 2026-05-14 | Truist Financial | $47 | 24.2% upside | |
| 2026-05-11 | Barclays | $37 |  2.2% downside | |
| 2026-05-08 | NeedhamMatthew Shea | $41 | 8.3% upside | |
| 2026-05-08 | Robert W. Baird | $45 | 18.9% upside | |
| 2026-04-15 | Robert W. Baird | $40 | 5.7% upside | |
| 2026-02-02 | BTIG | $40 | 5.7% upside | |
| 2025-12-12 | NeedhamMatthew Shea | $28 | 26% downside | |
| 2025-11-25 | Jefferies | $37 | 2.2% downside | |
| 2025-11-24 | BarclaysAndrew Mok | $26 | 31.3% downside | |
| 2025-04-01 | Barclays | $36 | 4.9% downside | |
| 2025-03-03 | Robert W. Baird | $50 | 32.1% upside | |
| 2024-10-03 | BTIGDavid Larsen | $70 | 84.9% upside | |
| 2024-08-15 | Robert W. BairdMichael Ha | $67 | 77% upside | |
| 2024-06-27 | Stifel NicolausChris O'Cull | $48 | 26.8% upside | |